The delivery of HIV care in the initial rapid scale-up of HIV care and treatment was based on existing clinic-based models, which are common in highly resourced settings and largely undifferentiated for individual needs. A new framework for treatment based on variable intensities of care tailored to the specific needs of different groups of individuals across the cascade of care is proposed here. Service intensity is characterised by four delivery components: (i) types of services delivered, (ii) location of service delivery, (iii) provider of health services and (iv) frequency of health services. How these components are developed into a service delivery framework will vary across countries and populations, with the intention being to improve acceptability and care outcomes. The goal of getting more people on treatment before they become ill will necessitate innovative models of delivering both testing and care. As HIV programmes expand treatment eligibility, many people entering care will not be 'patients' but healthy, active and productive members of society [1] . To take the framework to scale, it will be important to: (i) define which individuals can be served by an alternative delivery framework; (ii) strengthen health systems that support decentralisation, integration and task shifting; (iii) make the supply chain more robust; and (iv) invest in data systems for patient tracking and for programme monitoring and evaluation.
Introduction
The widespread devastation caused by the HIV pandemic has led to unprecedented increases in overseas development aid for health, much of it earmarked for care and treatment-related services in low-and middleincome countries [2] . The magnitude of HIV funding allowed for rapid strengthening of under-resourced health systems unaccustomed to providing chronic care and enabled the successful expansion of care and treatment services that have averted an estimated 5.5 million deaths since 1996 [3, 4] . Further expansion of the emergency scale-up, as currently constituted, is constrained by the donor funding environment [5, 6] , and subsequent increases in donor resources are unlikely.
A sequel of this success story, however, is that health systems have become even more overburdened. The models of delivery for HIV care developed for the initial rapid scaleup of HIV services were based on traditional clinic-based service models, common in highly resourced settings, and largely not modified to reflect individual needs. Even as the number of people on ART has grown to almost 12 million in low-and middle-income countries, protocols for frequent clinic follow-up have been perpetuated with very few changes, regardless of how long an individual has been on antiretroviral treatment (ART) or their clinical status. After the early rapid growth in clinic sites, expansion has slowed and ever-growing numbers of people receive care in clinics often with insufficient numbers of doctors, clinical officers and nurses [7] . As a result of traditional care models, HIV clinics are crowded and waiting times are long with many people waiting solely to pick up drug refills. Healthcare workers are overtaxed due to this high workload and, due to weak infrastructure, face challenges to provide care and follow-up according to the guidelines on which they have been trained.
These challenges have led to a mixed picture of effectiveness among the HIV care and treatment systems. On the one hand, individuals who have been linked to care and retained on ART achieve high rates of viral suppression [8] [9] [10] . However, studies report substantial loss to follow-up across all steps of the care cascade [6, 11] . Overburdened health systems, lack of patient-focused services, resource limitations and mixed quality of care have led to efforts to modify the delivery of HIV care in a framework that addresses the causes of poor retention. Task shifting is one of the most common approaches [12] . WHO has included task shifting in the 2013 Consolidated Guidelines as a way of providing care to a greater number of people at reduced cost or when there are insufficient healthcare workers in the public sector [13] . Other programmes have focused on decentralisation, shifting care to primary health clinics and to the communities in which people live [14] .
We describe a delivery framework which provides differential care and treatment services for specific, welldefined groups of people in an effort to improve service quality and access, adherence and retention, outcomes, efficiency, and cost of services. The framework has been variously termed optimised care, patient-centred/focused care, needs-based care or tiered care. Driven by a desire to provide care which people will use and to increase the efficiency and effectiveness of HIV care delivery, this framework aims to vary the intensity of both ART and pre-ART care based on individual need and to create more flexible, convenient and acceptable models of service delivery for patients, healthcare workers and health systems. In simple terms, the framework describes delivery of the right care at the right frequency to the right individuals by the right care providers in the right location at the right time. Although this concept is not new, it has not been extensively used by HIV care and treatment programmes in low-and middle-income countries to date. The framework involves providing differential intensity of care and treatment services across defined patient strata. Service intensity is characterised by four components, all centred on the needs of individuals: (i) types of services delivered; (ii) location of service delivery; (iii) provider of health services; and (iv) frequency of health services ( Figure 1) .
Each of these components represents a flexible lever for adjusting or modifying a model of care to serve a specific patient stratum in a given geographic or health system setting. Health system variables, such as geography, level of health facility and available cadres of health workers, and individual variables (distance to the health facility, clinical condition, social and economic situation, education level, rural/urban context, and mobility pattern) determine how levers are applied in a given location. How the framework is implemented will vary across countries and populations to best serve the needs of individuals. Similarly, individual eligibility criteria will vary by heath setting, with the intention being to improve patient acceptability and care outcomes.
Different intensities of service can be delivered within a single location or between locations. Distribution of individuals into strata for optimised care is determined by the needs and preferences as defined by specific characteristics ( Table 1 ). The distribution of individuals across care strata is dynamic due to the need for periodic upreferral or down-referral to more or less intensive care based on their current needs.
Models of care can be organised into three categories based on the location at which people receive services. Centralised, facility-based models can provide differential care within a single health facility, such as reduced frequency of visits or substitution of a clinical assessment visit by a pharmacy-only medication refill visit. Decentra-lised models of care provide pre-ART and ART services either by down-referring stable people or initiating and managing people at more peripheral health facilities [15, 16] . Other models decentralise care even further by providing care directly in the community or in the home (Figure 2 ).
There are critical enabling services that are levers for successful HIV health delivery regardless of location, intensity, and frequency of care and who delivers that care. The need for psycho-social support, transportation, child care, nutrition, legal and other services may be as important as how long people wait in clinic.
Examples and evidence from the literature
Application of individual elements of this care framework, notably decentralisation and task shifting, has increased significantly during the past few years and has been widely endorsed by the WHO and other agencies. However, there are few models that represent differential HIV care intensity across patient strata in either the peerreviewed literature or the grey/conference literature. While not a systematic review, the examples presented in Appendix 1 illustrate the key dynamics and outcomes of innovative models of care in the real world. The studies included in this analysis reported results from approximately 68 000 HIV-positive individuals in eight countries (Democratic Republic of the Congo, Kenya, Malawi, Mozambique, South Africa, Swaziland, Thailand and Uganda). See Appendix 1 for a detailed listing of studies and results.
All of the models analysed differentiated individuals on the basis of clinical stability on treatment to determine eligibility for an alternative framework of care. Eligibility was generally restricted to adults with CD4 count above a certain threshold (ranging from ≥50 to ≥350), a certain length of time on ART (from ≥4 weeks to ≥18 months and adherent), undetectable viral load and/or other clinical considerations (no opportunistic infections, no adverse reactions, not pregnant). The studies generally reported on outcomes (including loss to follow-up, mortality and adherence), and some studies reported changes in resource use (health system and/or cost per person per year, number of clinic visits).
Examples of models and evidence of impact
One study examined the cost-effectiveness of the centralised, facility-based model in an urban HIV clinic [17] . At the Infectious Diseases Institutes (IDI) in Kampala, Uganda, stable individuals are offered 3-monthly nurse visits, 6-monthly physician visits and monthly pharmacy-only ART refills. Individual outcomes were similar between those managed with monthly refill visits and standard monthly physician/nurse visits, but the cost per person per year fell from $610 per year to $496 for monthly refill-only visits, a decrease of nearly 20% [17] .
A clinic-based model that used a six-monthly clinical appointments (SMA) programme was initiated at the Chiradzulu District Hospital in rural Malawi and supported by M edecins Sans Fronti eres (MSF) to reduce waiting times and clinic staff workload using visit spacing and pharmacy-only visits [18] . This programme enrolled people stable on ART to receive 6-monthly clinical appointments with nurses and 3-monthly drug refill visits. Between January 2008 and mid-2013, 8528 adults were enrolled in SMA. Cohort retention at 36 months after SMA start was 94%; however, 2722 (33%) people had returned to standard clinical follow-up status. Reasons for SMA discontinuation and long-term treatment outcomes are being evaluated [18] .
A number of studies evaluated the impact of a decentralised, facility-based model in which stable individuals were down-referred from the HIV clinic (where care was generally provided by a doctor or clinical officer) to a primary care health centre (where the care was generally provided by a nurse). Among the 39 000 individuals included in a meta-analysis of this approach, loss to follow-up per 100 patient years was 7.4 (95% CI 6.0-9.3) in the primary care centre group compared to 13.4 in the HIV clinic group and mortality per 100 patient years was 2.8 (95% CI 1.1-7.3) in the primary care centre group compared to 8.4 in the HIV clinic group [14] .
At the Themba Lethu Clinic in Johannesburg, South Africa, stable individuals were down-referred to nursemanaged primary care clinics for treatment maintenance rather than being maintained at the HIV clinic [19] [20] [21] . More than 2000 individuals were down-referred as of 2011, and a matched cohort analysis found that downreferred people were less likely to die (HR 0.2; 95% CI 0.04-0.8), or be lost to follow-up (HR 0.3; 95% CI 0.2-0.6) or experience viral rebound (RR 0.6; 95% CI 0.4-0.9) [19] . The cost of care in primary clinics was 11% less than that in the HIV clinic [20] . Similar care models have been introduced in rural areas of South Africa with similar outcomes [21] .
A number of different approaches have decentralised care to the community or to the home. These models minimise the number of required clinic visits by utilising community health workers or peers to deliver care or treatment either at home or at a community meeting point. The community health workers ranged in education and training, and the qualifications and pay for community healthcare workers varied throughout the models. Some models used volunteers with few education In Mozambique, MSF has collaborated with the Health Ministry to implement and scale Community ART Groups (CAGs) throughout the country [25] . CAGs are groups of six individuals from which one rotating person in the group acts as the monthly ART collector for all members. Thus, each CAG member visits the clinic every 6 months. Eligible people must be stable on ART for >6 months and a CD4 count >200. Retention at 12, 24, 36 and 48 months, respectively, has been 97.7%, 96%, 93.4% and 91.8%, and mortality has been 2.1 per 100 person years [25] . CAGs are being implemented at varied degrees of scale in Lesotho, Zimbabwe, Malawi and South Africa.
Limitations of the studies
The field of research on alternative delivery frameworks is nascent, and a number of important questions remain. The articles we found did not discuss the impact on people who remained in standard clinic care or the impact on care providers. Only two studies were randomised, and most were retrospective cohort studies.
Implementation challenges
Challenges to implementing this framework include defining the most appropriate selection criteria for reduced intensity or non-clinic care, national and local regulatory and policy frameworks around reduced intensity of services, supply chain management and data systems for patient tracking and programme monitoring and evaluation.
Each country has their own regulatory frameworks that establish the scope of work for each cadre of healthcare worker. These regulations determine which cadre can initiate and/or manage antiretroviral therapy, dispense medications and perform laboratory tests. Further, regulations stipulate the frequency at which medications may be dispensed. These regulations significantly impact the ability to decentralise or temporally space care. For example, ARV dispensing for individual patients in Western Cape was maintained centrally at pharmacy level, while distribution of pre-packed and labelled ART was permitted at lower level facilities and through community-based adherence clubs. At present in many clinics in eastern, central and southern Africa, nurses cannot initiate ART, although WHO guidelines support it [28] .
Supply chains and stock management must be sufficiently robust to ensure stable ART distribution for decentralised primary health centres and communitydelivered ART along with longer durations of refills (ideally three monthly).
Robust data systems are necessary to track individuals across care sites as well as monitor overall programme effectiveness, in particular to ensure that retention in care can be tracked as patients move between care facilities or settings. Community-delivered ART requires simple and robust data collection. Unique identifiers, referral tools and data management systems are needed.
Conclusions
We believe this framework can guide policymakers into introducing and scaling up new approaches to delivery across the HIV cascade of care. The framework is driven by two needs: first, care that better meets the needs of people and assisting them to access care and remain in care for life; second, with donor funding for HIV expected to remain constant or decline in the coming years, this framework may provide a tool to provide this care more economically. The cost and cost-effectiveness of innovative models delivery of care needs further evaluation. The framework, with its levers and patient-centredness, addresses the losses described by others across the cascade of testing, linkage and retention in care [6] . Differentiated testing and linking strategies using new testing technologies such as oral self-test may hold promise in helping hard-to-reach populations know their HIV status [28-30]. The framework is equally applicable to pre-ART care as it is to ART care.
Scale-up of innovative models of care should be monitored and evaluated through a robust implementation science framework targeting critical questions about most effective and efficient approaches to providing care in varied settings. As best practices are identified, normative bodies and lead implementers should continue to develop toolkits 2 and guidelines to help countries and providers to implement these approaches. 
